{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:20:46Z","timestamp":1794856846498,"version":"4.9.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","award":["2020-SPF-22"],"award-info":[{"award-number":["2020-SPF-22"]}],"id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002537"],"award-info":[{"award-number":["UL1TR002537"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","annemergmed.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.annemergmed.2024.10.013","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T05:34:19Z","timestamp":1732080859000},"page":"240-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study"],"prefix":"10.1016","volume":"85","author":[{"given":"Jenny","family":"Koehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Spolsdoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana","family":"Negaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Krenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Polotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles","family":"Slocum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin T.","family":"Howington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeyaporn","family":"Sarangarm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia E.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Zepeski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Rech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5759-9857","authenticated-orcid":false,"given":"Brett","family":"Faine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2024.10.013_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"Foxman","year":"2014","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib2","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/cid\/civ076","article-title":"US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011","volume":"60","author":"Hicks","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2165\/00019053-200523110-00005","article-title":"Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy","volume":"23","author":"Brown","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib5","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib6","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3201\/eid2209.160148","article-title":"Fluoroquinolone-resistant and extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli infections in patients with pyelonephritis, United States","volume":"22","author":"Talan","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib7","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/acem.14545","article-title":"High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018\u20132020","volume":"29","author":"Faine","year":"2022","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1473-3099(18)30676-5","article-title":"Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study","volume":"19","author":"Low","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.idc.2007.10.002","article-title":"Urinary tract infections in the emergency department","volume":"22","author":"Abrahamian","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.annemergmed.2020.08.022","article-title":"Emergence of extended-spectrum \u03b2-lactamase urinary tract infections among hospitalized emergency department patients in the United States","volume":"77","author":"Talan","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jsps.2018.02.023","article-title":"Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: a systematic literature review","volume":"26","author":"Tenney","year":"2018","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib13","series-title":"Complicated urinary tract infections: developing drugs for treatment guidance for industry","year":"2018"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib14","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute;\u00a02024."},{"key":"10.1016\/j.annemergmed.2024.10.013_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194085","article-title":"Predicting urinary tract infections in the emergency department with machine learning","volume":"13","author":"Taylor","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib16","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10096-019-03679-9","article-title":"A\u00a0pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis","volume":"38","author":"Cattrall","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106560","article-title":"Comparing outcomes among outpatients treated for pyelonephritis with oral cephalosporins versus first-line agents","volume":"59","author":"Fosse","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib18","article-title":"A\u00a0retrospective review of oral cephalosporins versus fluoroquinolones for the treatment of pyelonephritis","volume":"17","author":"Lin","year":"2022","journal-title":"PLOS ONE"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib19","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ajem.2018.08.016","article-title":"Pyelonephritis treatment in the community emergency department: cephalosporins vs. first-line agents","volume":"36","author":"Vogler","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib20","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2022.285","article-title":"Outpatient treatment and clinical outcomes of bacteriuria in veterans: a retrospective cohort analysis","volume":"2","author":"Rovelsky","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/clinids\/24.3.457","article-title":"Oral administration of antibiotics: a rational alternative to the parenteral route","volume":"24","author":"MacGregor","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/ACI.0000000000000755","article-title":"Classifying cephalosporins: from generation to cross-reactivity","volume":"21","author":"Fernandez","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.annemergmed.2024.10.013_bib23","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/jac\/dkae070","article-title":"Empirical antimicrobial prescribing for pyelonephritis in patients discharged from 15 US emergency departments: an opportunity for improvement","volume":"79","author":"Rech","year":"2024","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064424011405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064424011405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T14:21:48Z","timestamp":1740061308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064424011405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0196064424011405"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2024.10.013","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study","name":"articletitle","label":"Article Title"},{"value":"Annals of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annemergmed.2024.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Emergency Physicians.","name":"copyright","label":"Copyright"}]}}